| George Arnold Alexander III, MPA |
| Partner, ALEX Companies |
| Associate Broker, Alexander Tiffany Southwest, LLC |
| Licensed Broker in TX, CO, NC, AL |
| [email protected] · +1 713.918.9951 |
| TREC Information About Brokerage Services · TREC Consumer Protection Notice |
AI in Healthcare
2026-08-11
The landscape of drug discovery is undergoing a profound transformation, with artificial intelligence at its core. Recent findings highlight AI's critical role in tackling previously "undruggable" disease targets. Mayo Clinic researchers, for instance, leveraged AI-assisted screening to identify an experimental drug for pancreatic cancer, a significant leap forward, as reported by Drug Target Review on August 11, 2026. This capability to rapidly screen thousands of compounds and pinpoint effective inhibitors for complex proteins promises to accelerate the development of novel therapies and expand the horizon of treatable diseases. What are your thoughts on AI's impact on oncology and personalized medicine development?
View and join any or all of our communities — AI, quantum, and real estate: https://alex-companies.com/linkedin/groups
If there's an AI, quantum, or real estate community you'd like to see us convene, tell us — this portfolio grows by request.
Licensed by the Texas Real Estate Commission. Broker: Alexander Tiffany Southwest, LLC · License #565194-BB.
Diane Hart Alexander, Chair & CEO, ALEX Companies · Designated Broker · #574877-B · George Arnold Alexander III, Partner, ALEX Companies · Associate Broker · #574878-B
Texas Real Estate Commission Information About Brokerage Services · TREC Consumer Protection Notice · trec.texas.gov
Diane Hart Alexander, Chair & CEO, ALEX Companies · Designated Broker · #574877-B · George Arnold Alexander III, Partner, ALEX Companies · Associate Broker · #574878-B
Texas Real Estate Commission Information About Brokerage Services · TREC Consumer Protection Notice · trec.texas.gov



